Joint Formulary & PAD

Umeclidinium with vilanterol (Anoro Ellipta) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Umeclidinium with vilanterol (Anoro Ellipta)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA LABA
Keywords :
Umeclidinium 55mcg/Vilanterol 22mcg, LAMA LABA, LAMA/LABA
Brand Names Include :
Anoro Ellipta
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
5

Other Indications

Below are listed other indications that Umeclidinium with vilanterol (Anoro Ellipta) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (1)

The locally preferred LAMA/LABA devices are as follows:

  • Spiolto Respimat (tiotropium / olodaterol soft mist inhaler). Re-usable device.
  • Anoro Ellipta (Umeclidinium / vilanterol DPI)
  • Ultibro Breezhaler (Glycopyrronium / indacaterol DPI)
  • Duaklir Genuair (Aclidinium / formoterol DPI)

Devices should be prescribed by BRAND

See full COPD guidelines for more information